Chlamydia pneumoniae Elispot

Chlamydia pneumoniae EliSpot
AONM/ArminLabs

"AONM have checklists that help identify the most likely viral or bacterial infections to test for, based on patient symptoms. Please see https://aonm.org/checklists-for-testing/ or contact AONM at 03331 210305 or email info@aonm.org. We also offer different viral and bacterial panels, and are always happy to advise on testing options."

Please note this test requires a blood draw, please organise a phlebotomist for your patient. A return courier fee of £50 is included in this test price

Description:
This test reflects the current Chlamydia pneumoniae activity of chronic and recent Chlamydia pneumoniae infections.

Chlamydophila pneumoniae is a species of Chlamydophila, an obligate intracellular bacterium that infects humans and is a major cause of pneumonia.  This atypical bacterium commonly causes pharyngitis, bronchitis, coronary artery disease and atypical pneumonia in addition to several other possible diseases including atherosclerosis. Also, the bacteria can play an important role in the exacerbation of asthma. It is found in nearly 60 % of asthmatic children between the ages of 5 and 15 years, and there is a direct link between the importance of the immune response against Chlamydia and the frequency of seizures.

The EliSpot is highly sensitive and can detect even one single Chlamydia pneumoniae-reactive T-cell. With detection levels that can be as low as one cell in 100,000, the EliSpot is one of the most sensitive cellular assays available.

Methodology:
Chlamydia pneumoniae EliSpot (T-Cell-Spot / IGRA: Interferon-Gamma-Release Assay)

When should I use:
When a recent or chronic case of Chlamydia pneumoniae infection is suspected.

Other details:
AONM has checklists that help identify the most likely viral or bacterial infections to test for, based on patient symptoms. Please see https://aonm.org/checklists-for-testing/  or contact AONM at 03331 210305 or email info@aonm.org. We also offer different viral and bacterial panels and are always happy to advise on testing options. The EliSpot can be helpful when monitoring therapies.

The EliSpot should usually become negative about 4 to 8 weeks after the completion of an effective therapy.

The symptoms of Chlamydia pneumoniae infection can include:

• Cough: Persistent cough that may be dry or productive.
• Sore Throat: Irritation or pain in the throat.
• Fever: Low-grade fever may be present.
• Shortness of Breath: Difficulty breathing or shortness of breath.
• Fatigue: Persistent tiredness and weakness.
• Chest Pain: Discomfort or pain in the chest.

Chlamydia pneumoniae infections can range from mild to severe and may present similarly to other respiratory infections.

Biomarkers

Chlamydia pneumoniae EliSpot

Specification

Specimen Type:

3 x CPDA tube

Vitality of T-cells for LTT: Up to 3 days

Phlebotomy Type:

Blood draw at home or in a clinical setting